Press Releases

EASTGATE BIOTECH ANNOUNCES ENGAGEMENT OF THE KELL GROUP LIMITED FOR INTRODUCTION TO VARIOUS SOURCES OF FUNDING FOR COMPANY INITIATIVES

August 30, 2017 by admin

“We are pleased to be working with a group that has a long standing reputation with a wide financial network," said Anna Gluskin, CEO of EastGate. “We are looking forward to moving into an exciting stage with some of our developments that have different requirements and funding strategies for which we believe The Kell Group Limited is best suited to assist in these plans and we hope will increase their shareholding position in the company”, concludes Gluskin.

Read more

EASTGATE BIOTECH’S RECENT ACQUISITION, OMNI SURGERY + ANTI-AGING CENTRE, PRESENTS THE OMNI SCHOOL OF MEDICAL ESTHETICS.

May 30, 2017 by admin

The mission statement of the OMNI School of Medical Esthetics is to ensure quality delivery of care while utilizing the latest techniques and technology. The program has two parts

Read more

EASTGATE BIOTECH CORP. ENGAGES A NEW INDEPENDENT AUDITOR

May 16, 2017 by admin

Eastgate pharmaceutical and biotech research company that develops, produces and distributes innovative and healthy nutraceuticals and pharmaceutical developments has announced today that it had selected Anton & Chia LLP as its new independent auditing firm.

Read more

EASTGATE BIOTECH ENGAGES AGENT TO IDENTIFY SUITABLE JOINT VENTURE PARTNERS AND SUPPLIERS IN THE PHILIPPINES

May 15, 2017 by admin

The agent, Roger Munoz, a principal of i-Power Philippines, a subsidiary of the ICube Group (www.icube.ph) a large holding group mostly for Nippon SME business in the Philippines, will work together with the company’s own Global Business Development team to act in EastGate’s interests

Read more

Eastgate Biotech Business Turnaround Expert Bill Abajian On The Positive Stocks Investor Influence Network

April 29, 2017 by admin

Mr. William (Bill) D. Abajian brings over 30 years experience in the pharmaceutical and biotechnology industry. He started his career at Electro Nucleonics Inc. in Fairfield, New Jersey where he served as the Vice President of Sales and Marketing between 1981-1988.

Read more

Eastgate Biotech Corp., Engages Gunpowder Capital Corp.

April 25, 2017 by admin

Toronto, Ontario, April 25th, 2017 – Gunpowder Capital Corp., (CSE: GPC), (CSE: GPC.PR.A), (Frankfurt: YS6N), (“Gunpowder”, “GPC” or the “Corporation”) announced today that entered into various agreements with Eastgate Biotech Corp., (OTCPink: ETBI) (“Eastgate”).

Read more

EASTGATE BIOTECH’S RECENT ACQUISITION OMNI SURGERY + ANTI-AGING CENTRE APPOINTS DR. ISHAAN SUNDAR AS MEDICAL DIRECTOR

April 12, 2017 by admin

Dr. Ishaan Sundar has assumed the role of Medical Director effective immediately. Educated by the American Academy of Aesthetic Medicine, American Cosmetic Cellular Medicine Association, Laser Sheer Training Academy and trained in Injectable Placements, Dr. Sundar brings over 20 years of extensive practice to the OMNI state-of-the-art centre.

Read more

EASTGATE BIOTECH CORPORATION AND AC NOVA TECHNOLOGIES (ATI PHARMA) ANNOUNCE A JOINT VENTURE

April 7, 2017 by admin

PHARMACEUTICAL BIOTECH RESEARCH COMPANY EASTGATE BIOTECH CORPORATION AND AC NOVA TECHNOLOGIES (ATI PHARMA) ANNOUNCE A JOINT VENTURE TO COMMERCIALIZE EVIDENCE-BASED NATURAL THERAPIES FOCUSED ON GLUCOSE BALANCE AND CARDIOVASCULAR HEALTH

Read more

Purchase and Sale Agreement to acquire Omni Surgery and Anti-Aging Centre

March 14, 2017 by admin

EastGate Biotech Corp.has entered into a Purchase and Sale Agreement to acquire OMNI Surgery and Anti-Aging Centre.

Read more
RSS Icon